CPHI & PMEC India 2026 expand to dual venues in Delhi NCR
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Subscribe To Our Newsletter & Stay Updated